Induction of Heymann nephritis with a gp330/megalin fusion protein
- PMID: 8623929
- PMCID: PMC1861581
Induction of Heymann nephritis with a gp330/megalin fusion protein
Abstract
There is considerable evidence that glomerular deposits in Heymann nephritis, a rat model of membranous nephritis, result from shedding of immune complexes formed on podocytes and that the principal antigen is part of the extracellular domain of a cell surface glycoprotein receptor called gp330 or megalin. It has also been reported that the immunogen that induces Heymann nephritis is a complex formed between gp330 and the receptor-associated protein RAP. The recent elucidation of the primary structure of gp330 makes it possible to investigate the ability of defined portions of gp330, devoid of RAP, to induce Heymann nephritis. In the present study we show that a gp330-glutathione-S-transferase fusion protein, containing 137 amino acid residues (1114 to 1250) of the ectodomain, induces active Heymann nephritis and that heterologous antibodies against this fusion protein produce passive Heymann nephritis. By immunofluorescence, typical glomerular immunoglobulin deposits were found, but complement components were lacking and the rats did not develop proteinuria. In the active model, we obtained evidence indicating that the deposits contained portions of the ectodomain of gp330, including regions other than those of the fusion protein. Thus, the deposits were stained by polyclonal antibodies to gp330 and to the gp330 fusion protein, as well as by two monoclonal antibodies reactive with portions of the ectodomain of gp330, only one of which reacted with the fusion protein in vitro. Antibodies against the cytoplasmic domain of gp330 did not stain. Furthermore, we found that RAP was able to bind to gp330 in the glomerular deposits but not to the gp330 fusion protein in vitro. The results show that the region of gp330 spanning amino acid residues 1114 to 1250 contains peptides capable of inducing pathogenic antibodies of Heymann nephritis without a contributory role of RAP.
Comment in
-
Molecular analysis of the pathological autoimmune antigens of Heymann nephritis.Am J Pathol. 1996 May;148(5):1331-7. Am J Pathol. 1996. PMID: 8623903 Free PMC article. Review. No abstract available.
Similar articles
-
Detection of two forms of GP330. Their role in Heymann nephritis.Am J Pathol. 1993 Aug;143(2):598-611. Am J Pathol. 1993. PMID: 8342605 Free PMC article.
-
Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein.J Am Soc Nephrol. 1995 Jul;6(1):61-7. doi: 10.1681/ASN.V6161. J Am Soc Nephrol. 1995. PMID: 7579071
-
Role of receptor-associated 39/45 kD protein in active Heymann nephritis.Kidney Int. 1995 Feb;47(2):432-41. doi: 10.1038/ki.1995.56. Kidney Int. 1995. PMID: 7723231
-
The Heymann nephritis antigenic complex: megalin (gp330) and RAP.J Am Soc Nephrol. 1995 Jul;6(1):35-47. doi: 10.1681/ASN.V6135. J Am Soc Nephrol. 1995. PMID: 7579068 Review.
-
gp330 and RAP: the Heymann nephritis antigenic complex.Ann N Y Acad Sci. 1994 Sep 10;737:96-113. doi: 10.1111/j.1749-6632.1994.tb44304.x. Ann N Y Acad Sci. 1994. PMID: 7944157 Review.
Cited by
-
Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway.Front Pharmacol. 2021 Nov 19;12:727874. doi: 10.3389/fphar.2021.727874. eCollection 2021. Front Pharmacol. 2021. PMID: 34867334 Free PMC article.
-
Advances of the experimental models of idiopathic membranous nephropathy (Review).Mol Med Rep. 2020 May;21(5):1993-2005. doi: 10.3892/mmr.2020.11014. Epub 2020 Mar 9. Mol Med Rep. 2020. PMID: 32186751 Free PMC article. Review.
-
A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.Pflugers Arch. 2017 Aug;469(7-8):997-1005. doi: 10.1007/s00424-017-2007-x. Epub 2017 Jun 8. Pflugers Arch. 2017. PMID: 28597189 Review.
-
Abundance of megalin and Dab2 is reduced in syncytiotrophoblast during placental malaria, which may contribute to low birth weight.Sci Rep. 2016 Apr 13;6:24508. doi: 10.1038/srep24508. Sci Rep. 2016. PMID: 27072056 Free PMC article.
-
Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.Acta Pharmacol Sin. 2015 Feb;36(2):188-99. doi: 10.1038/aps.2014.134. Epub 2015 Jan 26. Acta Pharmacol Sin. 2015. PMID: 25619396 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources